These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection. Elmer DS; Hathaway DK; Shokouh-Amiri HM; Hughes TA; Gaber LW; Gaber AO Transplant Proc; 1994 Apr; 26(2):536. PubMed ID: 7513456 [No Abstract] [Full Text] [Related]
4. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO Transplant Proc; 1994 Apr; 26(2):531-3. PubMed ID: 7513455 [No Abstract] [Full Text] [Related]
5. Pancreatic secretory trypsin inhibitor as a marker for early detection of rejection in canine pancreas allotransplantation. Suzuki Y; Kuroda Y; Kawamura T; Fujiwara H; Tanaka T; Saitoh Y Transplant Proc; 1989 Feb; 21(1 Pt 3):2793-4. PubMed ID: 2468240 [No Abstract] [Full Text] [Related]
6. Serum pancreatic secretory trypsin inhibitor monitoring for early diagnosis of pancreas allograft rejection in dogs. Suzuki Y; Kuroda Y; Fujino Y; Fujiwara H; Kawamura T; Saitoh Y Transplant Proc; 1990 Apr; 22(2):704-6. PubMed ID: 2327022 [No Abstract] [Full Text] [Related]
7. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes. Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379 [No Abstract] [Full Text] [Related]
8. Plasma pancreatic secretory trypsin inhibitor as a marker of pancreas graft rejection after combined pancreas-kidney transplantation. Suzuki Y; Kuroda Y; Sollinger HW; Reed AI; Hullett DA; Saitoh Y Transplantation; 1991 Sep; 52(3):504-7. PubMed ID: 1897024 [TBL] [Abstract][Full Text] [Related]
9. Histologic confirmation of acute rejection detected by urine cytology in pancreas transplant recipients. Radio SJ; Stratta RJ; Linder J; Wisecarver JL; Taylor RJ; Markin RS Transplant Proc; 1994 Apr; 26(2):529-30. PubMed ID: 8171539 [No Abstract] [Full Text] [Related]
10. Serum pancreatic secretory trypsin inhibitor (PSTI) level predicts early stage of pancreas allograft rejection. Suzuki Y Kobe J Med Sci; 1990 Apr; 36(1-2):23-35. PubMed ID: 1700186 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation. Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868 [No Abstract] [Full Text] [Related]
12. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage. Abendroth D; Capalbo M; Illner WD; Landgraf R; Land W Transplant Proc; 1992 Jun; 24(3):786-7. PubMed ID: 1376524 [No Abstract] [Full Text] [Related]
13. Pancreatic secretory trypsin inhibitor as a marker for early detection of rejection in canine pancreas allotransplantation. Kuroda Y; Suzuki Y; Kawamura T; Fujiwara H; Ashida T; Matsuo M; Yamamoto K; Tanaka T; Saitoh Y Transplantation; 1988 Oct; 46(4):493-5. PubMed ID: 3051554 [TBL] [Abstract][Full Text] [Related]
14. Is the incidence of kidney rejection episodes higher in combined kidney/pancreas than in single kidney transplant patients? Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):535. PubMed ID: 8171541 [No Abstract] [Full Text] [Related]